Table 1 Patient characteristics
|  | Overall (n = 190) |
|---|---|
Clinical | |
 Age (years) | 57 ± 12 |
 Male gender | 87% (165) |
 Body surface area | 2.0 ± 0.2 |
 Coronary Artery Disease Risk Factors |  |
  Hypertension | 47% (90) |
   Hypercholesterolemia | 54% (102) |
  Diabetes mellitus | 28% (53) |
  Tobacco use | 35% (66) |
  Family history | 30% (56) |
 Cardiovascular Medications |  |
  Beta-blocker | 91% (173) |
  ACEI/ARB | 60% (113) |
  Loop diuretic | 15% (28) |
  Statin | 93% (177) |
  Aspirin | 98% (186) |
  Thienopyridine | 83% (158) |
  Warfarin | 5% (9) |
  Nitroglycerin | 13% (25) |
Cardiac morphology/function | |
 Left Ventricle | |
  Ejection fraction (%) | 52.2 ± 13.3 |
  LV dysfunction (EF < = 55%) | 55% (105) |
  End-diastolic volume (ml) | 161.9 ± 49.2 |
  End-systolic volume (ml) | 81.6 ± 46.4 |
  Myocardial mass (g) | 137.9 ± 38.2 |
  Late gadolinium enhancement (present) | 98% (186) |
  Infarct size (% myocardium) | 14.5 ± 10.4 |
 Aortic Valve | |
  Bileaflet | 2% (3) |
  Thickening/ fibrocalcific changes | 12% (23) |
  Stenosis | 2% (4) |
  Regurgitation | 7% (13) |